CBT
XBI icon

Capital Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Capital Bank & Trust’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,650
Closed -$202K – 854
2019
Q3 		$202K Buy
+2,650
New +$220K ﹤0.01% 286

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Capital Bank & Trust's XBI Position: Q4 2019 in Review

Capital Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 2,650 shares — an estimated $202K sold.

Capital Bank & Trust first reported a position in XBI in Q3 2019 and held it in 1 quarter. The position peaked at $202K in Q3 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

  • Capital Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 2,650 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $202K.
  • Capital Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 1 quarter.
  • Capital Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $202K in Q3 2019.
  • 474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.